Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1983 Nov;42(2):783–788. doi: 10.1128/iai.42.2.783-788.1983

Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus.

A B Onderdonk, R L Cisneros, R T Bronson
PMCID: PMC264498  PMID: 6642651

Abstract

Previous studies with the guinea pig model for ulcerative colitis have shown that the inducing agent, carrageenan, does not provoke ulcerations in germfree guinea pigs, but animals monoassociated with Bacteroides vulgatus develop cecal ulcerations when fed carrageenan. In an effort to define the role of B. vulgatus in this model system, conventional guinea pigs were immunized with B. vulgatus before carrageenan treatment. Immunized animals developed both circulating antibody and positive skin tests for the homologous antigen. A comparison of B. vulgatus-immune and nonimmune carrageenan recipients after 30 days of carrageenan treatment revealed ulcerations of the ceca and large intestine in both groups, but the immune group developed more severe lesions than the nonimmune group. The most severe intestinal lesions were detected in B. vulgatus-immune animals fed both carrageenan and daily doses of viable B. vulgatus. Immune recipients of B. vulgatus alone did not develop ulcerations, but showed histological evidence of intestinal inflammation. Lesions observed in B. vulgatus-immune animals were most severe in the colon and rectum, in contrast to more severe cecal lesions detected in nonimmune carrageenan recipients. Similar experiments with Bacteroides fragilis as an antigen for immunization showed no difference between immune and nonimmune groups. These results suggest that immunization with B. vulgatus enhances the severity of carrageenan-induced colitis.

Full text

PDF
783

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grasso P., Sharratt M., Carpanini F. M., Gangolli S. D. Studies on carrageenan and large-bowel ulceration in mammals. Food Cosmet Toxicol. 1973 Aug;11(4):555–564. doi: 10.1016/s0015-6264(73)80326-8. [DOI] [PubMed] [Google Scholar]
  2. Onderdonk A. B., Bartlett J. G. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr. 1979 Jan;32(1):258–265. doi: 10.1093/ajcn/32.1.258. [DOI] [PubMed] [Google Scholar]
  3. Onderdonk A. B., Franklin M. L., Cisneros R. L. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun. 1981 Apr;32(1):225–231. doi: 10.1128/iai.32.1.225-231.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Onderdonk A. B., Hermos J. A., Bartlett J. G. The role of the intestinal microflora in experimental colitis. Am J Clin Nutr. 1977 Nov;30(11):1819–1825. doi: 10.1093/ajcn/30.11.1819. [DOI] [PubMed] [Google Scholar]
  5. Onderdonk A. B., Hermos J. A., Dzink J. L., Bartlett J. G. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology. 1978 Mar;74(3):521–526. [PubMed] [Google Scholar]
  6. Watt J., Marcus R. Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut. 1971 Feb;12(2):164–171. doi: 10.1136/gut.12.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES